SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-013553
Filing Date
2021-03-25
Accepted
2021-03-25 20:12:38
Documents
2
Period of Report
2021-03-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6410
2 EX-24 DOCUMENT attachment1.htm EX-24 4682
  Complete submission text file 0000899243-21-013553.txt   12432
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Issuer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O IKENA ONCOLOGY, INC. 50 NORTHERN AVENUE BOSTON MA 02210
Business Address
Ecsedy Jeffrey (Reporting) CIK: 0001848533 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40287 | Film No.: 21774239